The efficacy of amrubicin third‐line chemotherapy in patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective and historical study in a single institute-Reference-Cited by-同舟云学术

The efficacy of amrubicin third‐line chemotherapy in patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective and historical study in a single institute

Published:2019-07-27 Issue:9 Volume:10 Page:1805-1811
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Sonehara Kei¹^ORCID,Tateishi Kazunari¹,Fukushima Toshirou²,Komatsu Masamichi¹,Yamamoto Hiroshi¹,Koizumi Tomonobu²^ORCID,Hanaoka Masayuki¹

Affiliation:

1. First Department of Internal MedicineShinshu University School of Medicine Matsumoto Japan

2. Department of Comprehensive Cancer TherapyShinshu University School of Medicine Matsumoto Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13150

Reference23 articles.

1. A Statistical Study of Lung Cancer in the Annual of Pathological Autopsy Cases in Japan, from 1958 to 1997, with Reference to Time Trends of Lung Cancer in the World

2. Small Cell Lung Cancer

3. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

4. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis

5. A Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated Extensive-Stage Small Cell Lung Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history of SCLC patients treated in third-line and beyond: A retrospective real world study;Lung Cancer;2024-07

2. Comparison of the second-line treatments for patients with small cell lung cancer sensitive to previous platinum-based chemotherapy: A systematic review and Bayesian network analysis;Frontiers in Oncology;2023-03-16

3. Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report;Cancer Management and Research;2023-02

4. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer;Thoracic Cancer;2020-04-14

5. Amrubicin;Reactions Weekly;2019-10